Real-World Data for Clinical Research

Real-time access to clinical data from the largest global network of healthcare organizations

Real-World Data for Clinical Research

Real-time access to clinical data from the largest global network of healthcare organizations

Reduce Protocol Amendments

Apply a data-driven approach to your clinical trial design and feasibility process

Accelerate Patient Recruitment

Identify and fast track engagement with sites who have cohorts that meet trial criteria

Webinar Event

Leveraging A Medical Record-Enriched Patient Dataset for COVID-19 Research

Thursday, November 12, 2020
2pm ET / 11am PT

TriNetX is the global health research network that connects the world of drug discovery and development from pharmaceutical company to study site, and investigator to patient by sharing real-world data to make clinical and observational research easier and more efficient.

Optimize Clinical Research

Generate Real-World Evidence

Collaborate on Clinical Trials

Longitudinal Real-World Data

Real-time access to patient populations, driven and refreshed by electronic medical record (EMR) data, to determine protocol feasibility, cohort analysis, site identification and the generation of real-world evidence to support regulatory submissions.

Data Linking

Demographics

Diagnoses

Genomics

Lab Results

Longitudinal Patient History

Medications

Mortality

Oncology

Patient Location

Procedures

Provider Notes (NLP)

Tumor Registry

Vitals

Highly Intuitive Analytics

Quickly gain real-world insights into how patients are treated and their outcomes or conduct full-protocol driven observational research studies in a fraction of the usual time.

Global and Diverse Healthcare Research Network

Conduct region-specific studies compliant with local privacy regulations in over 30 countries.

Clinical Data for COVID-19 Research

Counts of possible COVID-19 patients based on a combination of ICD-10 diagnostic terms and confirmatory laboratory results occurring on or after January 20, 2020, as of October 27, 2020.

Better understand the risk factors, comorbidities and outcomes of COVID-19 patients

Recent Scientific Publications

Singh S, Khan A, Chowdhry M, Bilal M, Kochhar GS, Clarke K, Risk of Severe COVID-19 in Patients with Inflammatory Bowel Disease in United States. A Multicenter Research Network Study., Gastroenterology (2020), doi: https://doi.org/10.1053/j.gastro.2020.06.003.

Turk M, Landes S, Formica M, Goss K, Intellectual and developmental disability and COVID-19 case fatality trends: TriNetX analysis., Disability and Health Journal (2020), doi: https://doi.org/10.1016/j.dhjo.2020.100942.

Open Source from TriNetX

TriNetX believes in community involvement and the democratization of software tools. Open.TriNetX is our open source contribution to empowering the global research community. Our OPS to SNOMED CT Mapping solution is the beginning of what we plan to be a growing library of open source content, tools, and solutions.

News

Twitter

Our new partnership w/ @Medidata and @Datavant linking #clinicaltrial data w/ de-identified #EMR data from the #TriNetX network will be valuable for #COVID19 clinical trials by supporting the collection of additional safety and surveillance data. https://bit.ly/2G9gYuV

TriNetX has successfully renewed our certification to the ISO/IEC 27001:2013 Information Security Standard. Our #Ghent, #Belgium office also passed the full audit; expanding the scope of the certification. https://bit.ly/3mrNTdQ #informationsecurity

Honored to have our CEO, @gadi_lachman, recognized among so many inspiring leaders in the Entrepreneur Of The Year® 2020 New England program as an award winner! @EY_US https://go.ey.com/33E6s83 #EOYNE

Load More...